Pluristem Therapeutics Inc.
PSTI PLTR announced that it has priced a firm commitment
underwritten public offering of 8,000,000 units, with each unit consisting of
one share of the company's common stock and one warrant to purchase 0.35 of a
share of the company's common stock, at a purchase price of $4.00 per unit for
an aggregate gross offering amount of $32 million. The offering is expected to
close on or about September 19, 2012, subject to customary closing conditions.
Each warrant will be exercisable for a period of 5 years following the
issuance thereof at an exercise price of $5.00. The company has also granted
the underwriters a 30-day option to purchase up to 1,200,000 shares of common
stock and/or warrants to purchase up to 420,000 shares of common stock to
cover over-allotments, if any.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in